Title: Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group
Authors: Nordlinger, Bernard ×
Van Cutsem, Eric
Rougier, Philippe
Köhne, Claus-Henning
Ychou, Marc
Sobrero, Alberto
Adam, Rene
Arvidsson, Dag
Carrato, Alfredo
Georgoulias, Vassilis
Giuliante, Felice
Glimelius, Bengt
Golling, Markus
Gruenberger, Thomas
Tabernero, Josep
Wasan, Harpreet
Poston, Graeme #
Issue Date: Sep-2007
Publisher: Pergamon
Series Title: European Journal of Cancer vol:43 issue:14 pages:2037-45
Abstract: Liver resection offers the only chance of cure for patients with advanced colorectal cancer (CRC). Typically, the 5-year survival rates following liver resection range from 25% to 40%. Unfortunately, approximately 85% of patients with stage IV CRC have liver disease which is considered unresectable at presentation. However, the rapid expansion in the use of improved combination therapy regimens has increased the percentage of patients eligible for potentially curative surgery. Despite this, the selection criteria for patients potentially suitable for resection are not well documented and patient management by multidisciplinary teams, although essential, is still evolving. The goal of the European Colorectal Metastases Treatment Group is to establish pan-European guidelines for the treatment of patients with CRC liver metastases that can be adopted more widely by established treatment centres and to develop more accurate staging systems and evaluation criteria.
ISSN: 0959-8049
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Translational Research in GastroIntestinal Disorders
Clinical Digestive Oncology (+)
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science